Emergency Contraception
- 6 August 2002
- journal article
- case report
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 137 (3) , 180-189
- https://doi.org/10.7326/0003-4819-137-3-200208060-00010
Abstract
Emergency contraception is used to prevent pregnancy after a coital act not adequately protected by a regular method of contraception. In contrast to early medical abortion, emergency contraception prevents a pregnancy from starting and does not disrupt an established pregnancy. The most commonly used approaches consist of two oral doses of contraceptive steroids. The levonorgestrel-only regimen (levonorgestrel, 0.75 mg, repeated in 12 hours) appears to be more effective and better tolerated than the Yuzpe regimen (ethinyl estradiol, 100 microg, and levonorgestrel, 0.5 mg, repeated in 12 hours). In the largest randomized, controlled trial to date, levonorgestrel prevented about 85% of pregnancies that would have occurred without its use. Hormonal emergency contraception has no known medical contraindications, although it is not indicated for suspected or confirmed pregnancy. However, if hormonal emergency contraception is inadvertently taken in early pregnancy, neither the woman nor the fetus will be harmed. Nausea and vomiting associated with the Yuzpe regimen can be reduced by prophylactic use of meclizine. A strong medical and legal case exists for making hormonal emergency contraception available over the counter, as has happened in countries other than the United States. Easier access to and wider use of emergency contraception could dramatically lower the high rates of unintended pregnancy and induced abortion in the United States.Keywords
This publication has 59 references indexed in Scilit:
- Clinical Breast and Pelvic Examination Requirements for Hormonal ContraceptionJAMA, 2001
- Vaginal Misoprostol Administered 1, 2, or 3 Days After Mifepristone for Early Medical AbortionJAMA, 2000
- The morning-after pill — How long after?American Journal of Obstetrics and Gynecology, 1994
- Clotting factors after emergency contraceptionAdvances in Contraception, 1993
- Spermicides, hormonal contraception and congenital malformationsAdvances in Contraception, 1990
- Comparative pharmacokinetics of levonqrgestrel and ethinyloestradiol following intravenous, oral and vaginal administrationContraception, 1987
- A possible mechanism of action of danazol and an ethinylestradiol/ norgestrel combination used as postcoital contraceptive agentsContraception, 1986
- A study of interaction of low-dose combination oral contraceptive with ampicillin and metronidazoleContraception, 1980
- Study on the action of D-norgestrel as a postcoital contraceptive agentContraception, 1975
- The hormonal and peripheral effects of -norgestrel in postcoital contraceptionContraception, 1974